首页 | 本学科首页   官方微博 | 高级检索  
     

应用等位基因特异性PCR和多重差别PCR检测肺癌患者CYP1A1和GSTM1的遗传多态性
引用本文:陈森清,许林,马国建,吴建中,薛开先. 应用等位基因特异性PCR和多重差别PCR检测肺癌患者CYP1A1和GSTM1的遗传多态性[J]. 癌变.畸变.突变, 1999, 0(3)
作者姓名:陈森清  许林  马国建  吴建中  薛开先
作者单位:江苏省肿瘤防治研究所
摘    要:本文对等位基因特异性PCR(Alelespecific,AS)和多重差别(Multiplexdiferential,MD)PCR技术进行了优化,并用此法联合检测了105例江苏地区健康人群及68例肺癌患者CYP1A1、GSTM1的等位基因型。结果表明:ASPCR及MDPCR采用的设立双参照扩增体系,可一次同时检测CYP1A1和GSTM1的等位基因型。在肺癌患者组中,CYP1A1的突变型Val/Val的频率12/68(17.6%)约为健康组9/105(8.57%)的205倍,而GSTM1纯合缺失的频率,肺癌组为39/68(573%),与健康对照组42/105(40%)相比,亦有显著增加(P<0.05)。

关 键 词:等位基因特异性PCR;多重差别PCR;遗传多态;肺癌

IDENTIFICATION OF GENETIC POLYMORPHISM OF CYP1A1 AND GSTM1 IN LUNG CANCER PATIENTS BY USING ALLELESPECIFIC PCR AND MULTIPLEX DIFFERENTIAL PCR
Abstract:Allelespecific PCR(ASPCR) and multiplex differential PCR (MDPCR) were used to identify the genotypes of CYP1A1 and GSTM1 in 68 lung cancer patients and 105 healthy controls. The results showed that genotypes of CYP1A1 and GSTM1 could be detected simultaneously with ASPCR and MDPCR; The frequency of CYP1A1Val/Val in lung cancer patients group was 12/68(17.6%), about 2.05fold than that in healthy controls 9/105(8.57%), and the frequency of GSTM1 0/0 was 39/68(57.4%), remarkably higher compared with 42/105(40%) in healthy controls ( P <0.05)
Keywords:allelespecific PCR  multiplex differential PCR   polymorphism  CYP1A1  GSTM1  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号